yneL Antibody

What is yneL protein and why is it studied in E. coli research?

yneL (Uniprot No. P76138) is a protein found in Escherichia coli strain K12 that has been implicated in bacterial stress response mechanisms. The protein is relatively understudied compared to other E. coli proteins, making antibodies against it valuable tools for exploring its function and regulation in bacterial systems. Researchers typically investigate yneL in studies focused on bacterial gene regulation, stress responses, and potentially antimicrobial resistance mechanisms. The antibody enables visualization and quantification of this protein in various experimental conditions.

What are the key specifications of the commercially available yneL Antibody?

The yneL Antibody (CSB-PA300539XA01ENV) is a polyclonal antibody raised in rabbit against recombinant Escherichia coli (strain K12) yneL protein . It is specifically designed for E. coli (strain K12) reactivity and has been validated for Western blotting (WB) and ELISA applications.

Technical Specifications Table:

What is the recommended protocol for using yneL Antibody in Western blotting?

When using yneL Antibody for Western blotting of E. coli samples, researchers should follow this optimized protocol:

• Sample Preparation:

  • Grow E. coli K12 strain to desired phase (log, stationary, or stress-induced)

  • Harvest cells and lyse using appropriate buffer (e.g., B-PER with protease inhibitors)

  • Determine protein concentration (Bradford or BCA assay)

  • Prepare samples in Laemmli buffer with reducing agent

• Gel Electrophoresis and Transfer:

  • Load 10-30 μg protein per well on 12-15% SDS-PAGE gel

  • Run gel at 100-120V until sufficient separation

  • Transfer to PVDF or nitrocellulose membrane (25V for 1.5 hours or 10V overnight)

• Antibody Incubation:

  • Block membrane with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

  • Dilute yneL Antibody 1:500 to 1:2000 in blocking buffer (optimize for your specific lot)

  • Incubate membrane with primary antibody overnight at 4°C with gentle agitation

  • Wash membrane 3-5 times with TBST (5 minutes each)

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000) for 1 hour

  • Wash 3-5 times with TBST

• Detection and Analysis:

  • Apply ECL substrate and image using appropriate detection system

  • Expected molecular weight for yneL protein is consistent with the annotated size in databases

For optimal results, always include appropriate positive controls (recombinant yneL protein or E. coli K12 lysate under conditions known to express yneL) and negative controls (lysate from yneL knockout strain if available).

How can yneL Antibody be optimized for ELISA applications?

For ELISA applications with yneL Antibody, researchers should consider the following optimization strategies:

• Direct ELISA Protocol:

  • Coat plates with purified E. coli lysate (2-10 μg/ml) in carbonate buffer (pH 9.6) overnight at 4°C

  • Block with 1-3% BSA in PBS for 1-2 hours at room temperature

  • Add diluted yneL Antibody (start with 1:500-1:2000 dilution range)

  • Incubate for 1-2 hours at room temperature or overnight at 4°C

  • Add HRP-conjugated secondary antibody

  • Develop with TMB substrate and read at 450 nm

• Optimization Parameters:

  Parameter	Optimization Range	Notes
  Coating Concentration	1-10 μg/ml	Titrate to determine optimal signal-to-noise ratio
  Blocking Agent	BSA, casein, non-fat milk	Test multiple blockers to reduce background
  Primary Antibody Dilution	1:500-1:5000	Create dilution series to find optimal concentration
  Incubation Temperature	4°C, RT, 37°C	May affect binding affinity and specificity
  Incubation Time	1-16 hours	Longer times may increase sensitivity but could raise background
  Wash Buffer	PBS-T, TBS-T	Test different detergent concentrations (0.05-0.1% Tween-20)

• Sandwich ELISA Considerations:
  If developing a sandwich ELISA, a capture antibody specific to a different epitope of yneL would be required, which may necessitate additional antibody development or commercial sourcing.

How does bacterial growth condition affect yneL protein expression and antibody detection?

The expression of yneL protein in E. coli can vary significantly based on growth conditions, potentially affecting antibody detection sensitivity. Researchers should consider:

Expression Variation Table:

When designing experiments:

• Include time course studies to capture temporal changes in expression

• Consider comparing wild-type to stress-response mutants

• Normalize loading using housekeeping proteins (e.g., GroEL or DnaK)

• Pre-validate detection limits with recombinant protein standard curves

The correlation between growth conditions and yneL expression provides valuable insights into its physiological role in bacterial stress responses and adaptation.

What cross-reactivity concerns exist when using yneL Antibody with non-K12 E. coli strains or other bacterial species?

While the yneL Antibody is specifically raised against and tested for E. coli K12 strain yneL protein , researchers investigating other bacterial strains should consider potential cross-reactivity:

• Sequence Homology Analysis:

  • Before testing with non-K12 strains, perform bioinformatic analysis of yneL sequence conservation

  • BLAST or multiple sequence alignment can identify potential epitope conservation

• Cross-Reactivity Testing Protocol:

  • Run Western blots with equal protein loading from:

    • E. coli K12 (positive control)

    • Target non-K12 E. coli strains

    • Related Enterobacteriaceae species

    • Unrelated bacterial species (negative controls)

  • Compare band patterns and intensities

• Validation Methods:

  • Pre-adsorption of antibody with recombinant yneL protein to confirm specificity

  • Testing in yneL knockout strains as negative controls

  • Mass spectrometry confirmation of detected bands

Cross-reactivity can represent either a limitation or an opportunity, depending on research objectives. Documentation of cross-reactivity patterns enhances the utility of this antibody for broader microbiology research.

What are common sources of false negatives when using yneL Antibody, and how can they be addressed?

False negatives in yneL Antibody experiments can stem from multiple sources. Here's a comprehensive troubleshooting guide:

Troubleshooting False Negatives:

For ELISA-specific false negatives, also consider:

• Adsorption issues with the target protein to the plate

• Inappropriate blocking agents masking epitopes

• Buffer incompatibilities affecting antibody binding

Implementing systematic quality control steps throughout the protocol can help identify the source of false negatives early in the experimental process.

How can researchers validate the specificity of yneL Antibody binding in their experimental system?

Validating antibody specificity is crucial for confident interpretation of results. For yneL Antibody, consider these validation approaches:

• Genetic Validation:

  • Compare wild-type E. coli K12 with yneL gene deletion mutant

  • Use CRISPR-interference or antisense RNA to knockdown yneL expression

  • Complement deletion with tagged yneL expression construct

• Molecular Validation:

  • Pre-adsorption/competition assay with purified recombinant yneL protein

  • Peptide competition with synthesized epitope peptides

  • Cross-validate using antibodies raised against different epitopes (if available)

• Technical Validation:

  • Perform immunoprecipitation followed by mass spectrometry

  • Correlation of antibody signal with mRNA levels (RT-qPCR)

  • Correlation with GFP-tagged yneL expression (if applicable to your system)

• Controls to Include:

  • Positive control: Recombinant yneL protein

  • Negative control: Non-target protein of similar size

  • Technical control: Secondary antibody only

A validated antibody should demonstrate:

• Signal in samples containing the target protein

• Absence of signal in samples lacking the target

• Signal reduction/elimination in competition assays

• Correlation with orthogonal measures of protein abundance

What are the recommended quantification methods for yneL protein levels in comparative studies?

For rigorous quantitative analysis of yneL protein levels using the yneL Antibody, researchers should implement:

• Western Blot Quantification:

  • Use digital image capture with linear dynamic range

  • Include a standard curve of recombinant yneL protein (5-100 ng range)

  • Normalize to loading controls (e.g., GroEL, DnaK, or total protein stain)

  • Analyze with appropriate software (ImageJ, Image Lab, etc.)

  • Report data as fold-change relative to control conditions

• ELISA Quantification:

  • Generate standard curve using purified recombinant yneL (0.1-100 ng/ml)

  • Ensure samples fall within the linear range of standard curve

  • Run technical triplicates for all samples and standards

  • Calculate concentration using four-parameter logistic regression

• Statistical Analysis Recommendations:

  Comparison Type	Recommended Statistical Test	Minimum Sample Size
  Two conditions	Student's t-test or Mann-Whitney	n=3-5 biological replicates
  Multiple conditions	ANOVA with post-hoc test	n=3-5 per condition
  Time course	Repeated measures ANOVA	n=3 with 4+ time points
  Dose response	Non-linear regression	5-7 concentrations

• Data Visualization Best Practices:

  • Include representative blot images alongside quantification

  • Present normalized data with appropriate error bars

  • Indicate statistical significance levels clearly

  • Consider showing individual data points alongside means

How should researchers design experiments to study yneL protein interactions using this antibody?

When investigating protein-protein interactions involving yneL using the yneL Antibody, consider these experimental design principles:

• Co-Immunoprecipitation (Co-IP) Strategy:

  • Use mild lysis conditions to preserve protein complexes

  • Pre-clear lysates with protein A/G beads

  • Incubate cleared lysates with yneL Antibody (2-5 μg per mg of protein)

  • Include proper controls:

    • IgG isotype control

    • Lysate from yneL knockout strain

    • Pre-immune serum control if available

  • Analyze by SDS-PAGE followed by silver staining or Western blotting

  • Identify interaction partners by mass spectrometry

• Proximity Ligation Assay (PLA) Approach:

  • Fix E. coli cells with 4% paraformaldehyde

  • Permeabilize with appropriate agent (lysozyme/EDTA)

  • Use yneL Antibody (1:500) together with antibody against suspected interaction partner

  • Follow PLA protocol with species-appropriate probes

  • Quantify interaction signals per cell using fluorescence microscopy

• Crosslinking Mass Spectrometry Integration:

  • Treat living cells with membrane-permeable crosslinkers

  • Immunoprecipitate using yneL Antibody

  • Analyze crosslinked peptides by mass spectrometry

  • Validate identified interactions by reciprocal Co-IP or genetic approaches

• Experimental Controls Checklist:

  Control Type	Purpose	Implementation
  Input Control	Verify protein expression	5-10% of lysate before IP
  Negative Control	Assess non-specific binding	IP with irrelevant antibody
  Specificity Control	Confirm antibody specificity	Pre-incubation with blocking peptide
  Reciprocal IP	Validate interaction	IP with antibody to interaction partner
  Technical Control	Assess method reproducibility	Replicate experiments ≥3 times

Proper experimental design for interaction studies requires careful consideration of buffer conditions, crosslinking methods, and validation approaches to distinguish true from false interactions.